Filing Details
- Accession Number:
- 0001209191-21-068582
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-08 18:06:01
- Reporting Period:
- 2021-12-07
- Accepted Time:
- 2021-12-08 18:06:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1619856 | Caribou Biosciences Inc. | CRBU | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1231321 | G Barbara Mcclung | 2929 7Th Street, Suite 105 Berkeley CA 94710 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-12-07 | 12 | $2.69 | 342,856 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2021-12-07 | 6,115 | $2.69 | 348,971 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option to purchase Common Stock | Disposition | 2021-12-07 | 12 | $0.00 | 12 | $2.69 |
Common Stock | Option to purchase Common Stock | Disposition | 2021-12-07 | 6,115 | $0.00 | 6,115 | $2.69 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
77 | 2028-06-11 | No | 4 | X | Direct | |
74,836 | 2029-09-30 | No | 4 | X | Direct |
Footnotes
- These shares were acquired pursuant to the exercise of a stock option, as reported in Table II below.
- The exercise price for this stock option was incorrectly reported as $2.68 per share on the reporting person's Form 3 filed on July 22, 2021.
- The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on June 12, 2022, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.
- The shares subject to this option have vested or will vest in equal monthly installments until the option is fully vested on October 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.